Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
Resource Type
Article
Authors
Pinto, Carmine ; Zucali, Paolo Andrea ; Pagano, Maria ; Grosso, Federica ; Pasello, Giulia ; Garassino, Marina Chiara ; Tiseo, Marcello ; Soto Parra, Hector ; Grossi, Francesco ; Cappuzzo, Federico ; de Marinis, Filippo ; Pedrazzoli, Paolo ; Bonomi, Maria ; Gianoncelli, Letizia ; Perrino, Matteo ; Santoro, Armando ; Zanelli, Francesca ; Bonelli, Candida ; Maconi, Antonio ; Frega, Stefano ; Gervasi, Erika ; Boni, Luca ; Ceresoli, Giovanni Luca
Source
In The Lancet Oncology October 2021 22(10):1438-1447
Subject
Primary Research Articles
Language
ISSN
1470-2045